Want to join the conversation?
$CAH 4Q15 Call: We finished Fiscal 2015 with a very strong fourth quarter. Revenues increased 20%, non-GAAP operating earnings increased 33% and we reported non-GAAP EPS of $1.00. Harvard Drug strengthens our capabilities in generics and marketing reach.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?